Skip to main content
TipRanks
Go Ultimate75% OFF

Peter Haggarty Insider Profile

4 Followers

Peter Haggarty, former Chief Medical Officer at Perk Labs, holds 0.00 shares in Perk Labs (Ticker: TSE:PERK). Most recently, Peter Haggarty Sold 94,821 shares of Perk Labs on Nov 02, 2017 for an estimated value of C$77.39K.

Peter Haggarty's Trading History

PERK
Perk Labs
Nov 02, 2017―Informative Sell77.39KC$0.00
TSE:PERK
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 02, 2017Uninformative SellC$15.00K100,000C$0.15――
Nov 02, 2017Informative SellC$77.39K94,821C$0.82+82.20%―
Oct 16, 2017Uninformative SellC$15.00K100,000C$0.15――
Oct 13, 2017Informative SellC$22.80K25,000C$0.91+57.00%―
Oct 13, 2017Informative SellC$51.75K50,000C$1.04+57.00%―

You May Also Like

Peter Haggarty insider profile FAQ

What is the percentage of profitable transactions made by Peter Haggarty?
The percentage of profitable transactions made by Peter Haggarty is 80%.
What is the average return per transaction made by Peter Haggarty?
The average return per transaction made by Peter Haggarty is 44.40%.
What stocks does Peter Haggarty hold?
Peter Haggarty holds: TSE:PERK stocks.
What was Peter Haggarty’s latest transaction?
Peter Haggarty’s latest transaction was an Informative Sell of C$77.39K.
What was Peter Haggarty's most profitable transaction?
Peter Haggarty’s most profitable transaction was an Informative Sell of TSE:PERK stock on November 2, 2017. The return on the trade was 82.20%.
What is Peter Haggarty's role in Perk Labs?
Peter Haggarty's role in Perk Labs is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.